183 related articles for article (PubMed ID: 37606485)
1. Pembrolizumab-Induced Lichen Planus Pemphigoides in a Patient with Metastatic Adrenocortical Cancer: A Case Report and Literature Review.
Madan V; Marchitto MC; Sunshine JC
Dermatopathology (Basel); 2023 Aug; 10(3):244-258. PubMed ID: 37606485
[TBL] [Abstract][Full Text] [Related]
2. Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade.
Wat M; Mollanazar NK; Ellebrecht CT; Forrestel A; Elenitsas R; Chu EY
J Cutan Pathol; 2022 Nov; 49(11):978-987. PubMed ID: 36054729
[TBL] [Abstract][Full Text] [Related]
3. Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic Merkel cell carcinoma.
Kwon CW; Murthy RK; Kudchadkar R; Stoff BK
JAAD Case Rep; 2020 Oct; 6(10):1045-1047. PubMed ID: 32995442
[No Abstract] [Full Text] [Related]
4. Lichen planus pemphigoides induced by anti-PD-1 antibody: A case only involved in oral mucosa with excellent topical treatment efficiency.
Wang S; Sun J; Deng S; Wu L; Li W; Ye T; Wu F; Wu Y; Zhou H
J Cutan Pathol; 2024 Feb; 51(2):114-118. PubMed ID: 37846754
[TBL] [Abstract][Full Text] [Related]
5. Lichen Planus Pemphigoides Associated With PD-1 and PD-L1 Inhibitors: A Case Series and Review of the Literature.
Boyle MM; Ashi S; Puiu T; Reimer D; Sokumbi O; Soltani K; Onajin O
Am J Dermatopathol; 2022 May; 44(5):360-367. PubMed ID: 35120032
[TBL] [Abstract][Full Text] [Related]
6. Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab.
Shah RR; Bhate C; Hernandez A; Ho CH
Dermatol Ther; 2022 May; 35(5):e15432. PubMed ID: 35266258
[TBL] [Abstract][Full Text] [Related]
7. Lichen Planus Pemphigoides Induced by Enalapril: A Case Report and a Review of Literature.
Onprasert W; Chanprapaph K
Case Rep Dermatol; 2017; 9(3):217-224. PubMed ID: 29282395
[TBL] [Abstract][Full Text] [Related]
8. Challenges and pitfalls between lichen planus pemphigoides and bullous lichen planus.
Papara C; Danescu S; Sitaru C; Baican A
Australas J Dermatol; 2022 May; 63(2):165-171. PubMed ID: 35196400
[TBL] [Abstract][Full Text] [Related]
9. The clinical evolution of lichen planus pemphigoides.
Alkul M; Truitt J; Tarbox MB
Proc (Bayl Univ Med Cent); 2022; 35(3):352-353. PubMed ID: 35518823
[TBL] [Abstract][Full Text] [Related]
10. Childhood lichen planus pemphigoides: a case report and review of the literature.
Cohen DM; Ben-Amitai D; Feinmesser M; Zvulunov A
Pediatr Dermatol; 2009; 26(5):569-74. PubMed ID: 19840313
[TBL] [Abstract][Full Text] [Related]
11. Childhood lichen planus pemphigoides triggered by chickenpox.
Mohanarao TS; Kumar GA; Chennamsetty K; Priyadarshini T
Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S98-S100. PubMed ID: 25593817
[TBL] [Abstract][Full Text] [Related]
12. Pembrolizumab-induced rash in a patient with angiosarcoma.
Qian J; Kubicki SL; Curry JL; Jahan-Tigh R; Benjamin R; Heberton M; Nelson KC
JAAD Case Rep; 2022 Nov; 29():21-24. PubMed ID: 36186410
[No Abstract] [Full Text] [Related]
13. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.
Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ
J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience.
Merli M; Accorinti M; Romagnuolo M; Marzano A; Di Zenzo G; Moro F; Antiga E; Maglie R; Cozzani E; Parodi A; Gasparini G; Sollena P; De Simone C; Caproni M; Pisano L; Fattore D; Balestri R; Sena P; Vezzoli P; Teoli M; Ardigò M; Vassallo C; Michelerio A; Satta RR; Dika E; Melotti B; Ribero S; Quaglino P
Front Med (Lausanne); 2023; 10():1208418. PubMed ID: 37547602
[TBL] [Abstract][Full Text] [Related]
15. Lichen Planus Pemphigoides: From Lichenoid Inflammation to Autoantibody-Mediated Blistering.
Hübner F; Langan EA; Recke A
Front Immunol; 2019; 10():1389. PubMed ID: 31312198
[TBL] [Abstract][Full Text] [Related]
16. Lichen planus-like lesion preceding bullous pemphigoid development after programmed cell death protein-1 inhibitor treatment.
Sugawara A; Koga H; Abe T; Ishii N; Nakama T
J Dermatol; 2021 Mar; 48(3):401-404. PubMed ID: 33184934
[TBL] [Abstract][Full Text] [Related]
17. Bullous lichen planus and lichen planus pemphigoides--clinico-pathological comparisons.
Gawkrodger DJ; Stavropoulos PG; McLaren KM; Buxton PK
Clin Exp Dermatol; 1989 Mar; 14(2):150-3. PubMed ID: 2598489
[TBL] [Abstract][Full Text] [Related]
18. Pembrolizumab-Induced Lichen Planus in a Patient With Non-Small-Cell Lung Carcinoma (NSCLC) That Correlates to Therapeutic Response.
Sehbai A; Hamid MA; Ibrahim Z
Cureus; 2022 Nov; 14(11):e31454. PubMed ID: 36523676
[TBL] [Abstract][Full Text] [Related]
19. Narrowband UVB-induced lichen planus pemphigoide.
Mandy Chan WM; Lee JS; Thiam Theng CS; Chua SH; Boon Oon HH
Dermatol Reports; 2011 Oct; 3(3):e43. PubMed ID: 25386295
[TBL] [Abstract][Full Text] [Related]
20. Case report: Successful treatment of non-bullous lichen planus pemphigoides with dupilumab.
Li SZ; Xie YH; Wang SH; Fang RY; Jin HZ; Zuo YG
Front Med (Lausanne); 2022; 9():1023458. PubMed ID: 36590953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
